Genelux Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Revenue	0.17	11.07	0	0
Revenue Growth (YoY)	-98.46%	-	-	-
Gross Profit	0.17	11.07	0	0
Selling, General & Admin	11.57	5	8.29	6.2
Research & Development	12.77	9.08	6.32	6.23
Operating Expenses	24.34	14.08	14.61	12.42
Operating Income	-24.17	-3.01	-14.61	-12.42
Interest Expense / Income	0.17	1.15	1.22	1.15
Other Expense / Income	3.96	-0.06	0.54	0.07
Pretax Income	-28.3	-4.11	-16.38	-13.64
Income Tax	0	1.1	0	0
Net Income	-28.3	-5.21	-16.38	-13.64
Shares Outstanding (Basic)	24	9	9	25
Shares Outstanding (Diluted)	24	9	9	25
Shares Change	167.97%	0.92%	-63.98%	-
EPS (Basic)	-1.16	-0.57	-1.81	-0.54
EPS (Diluted)	-1.16	-0.57	-1.81	-0.54
Free Cash Flow	-21.3	-3.62	-6.59	-7.23
Free Cash Flow Per Share	-0.87	-0.40	-0.73	-0.29
Gross Margin	100.00%	100.00%	-	-
Operating Margin	-14214.71%	-27.22%	-	-
Profit Margin	-16645.29%	-47.05%	-	-
Free Cash Flow Margin	-12529.41%	-32.71%	-	-
EBITDA	-27.63	-2.4	-14.26	-11.84
EBITDA Margin	-16250.00%	-21.72%	-	-
Depreciation & Amortization	0.5	0.55	0.9	0.66
EBIT	-28.12	-2.96	-15.16	-12.5
EBIT Margin	-16543.53%	-26.72%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).